14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis

NCT03999528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2020-06-09

No results posted yet for this study

Summary

Is to investigate the relation between 14-3-3η protein, disease activity, and bone mineral density in female patients with rheumatoid arthritis.

Conditions

Interventions

DIAGNOSTIC_TEST

14-3-3η Protein assay

blood sampling for assessment of serum 14-3-3η Protein

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • AHMED ABOGAMAL · Al-Azhar Faculty of medicine- Cairo

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2019-08-01
Completion
2019-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03999528 on ClinicalTrials.gov